XML 42 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of restricted common stock
   Number of shares   Weighted
average
grant date
fair value
 
Non–vested at January 1, 2021   477,286   $9.30 
Granted   66,451   $3.98 
Vested   (305,094)  $8.41 
Non–vested at December 31, 2021   238,643   $9.31 

 

Schedule of restricted stock units
   Number of
shares
   Weighted average
grant date
fair value
 
Non–vested at January 1, 2021   1,499,933   $2.49 
Granted   1,734,197   $2.00 
Vested   (1,000,477)  $2.04 
Forfeited   (26,316)  $1.98 
Non–vested at December 31, 2021   2,207,337   $2.34 

 

Schedule of warrant activity
   Number of
Shares
   Weighted
Average
Exercise
Price (USD)
   Weighted
Average
Contractual
Life
(years)
   Intrinsic
Value
(USD)
 
Outstanding - January 1, 2021   55,303,832   $5.92    4.73      
Granted   2,483,660   $6.90           
Exercised   (16,775,143)  $1.40           
Outstanding – December 31, 2021   41,012,349   $7.82    3.59   $1,655,659 
Exercisable – December 31, 2021   41,012,349   $7.82    3.59   $1,655,659